Latest Breaking News On - Transhuman capital - Page 1 : comparemela.com

Kriya Therapeutics Raises $270M in Series C Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

North carolinaUnited statesResearch triangle parkShankar ramaswamyDexcel pharmaRd fundKriya therapeutics incKriya therapeuticsRedwood cityPatient square capitalBluebird venturesForesite capitalLightswitch capitalNarya capitalTranshuman capitalChief executive officer

Durham s Kriya Adds $270M to Coffers, Bringing Total Raised to Date to $450 5M for Gene Therapies

Durham's Kriya Therapeutics just added $270 million to its coffers, bringing its total raised to date to roughly $450 million for novel gene therapies

United statesNorth carolinaPalo altoJim momtazeeFraser wrightRoger jeffsAravind asokanShankar ramaswamyDexcel pharmaRd fundDuke university priya kishnaniCarolina biotechnology centerKriya therapeuticsPatient square capitalBluebird venturesForesite capital

Kriya Raises $270 Million to Advance Fully Integrated Gene Therapy Engine

Kriya Raises $270 Million to Advance Fully Integrated Gene Therapy Engine
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

North carolinaUnited statesResearch triangle parkShankar ramaswamyDexcel pharmaRd fundSquare capitalBluebird venturesForesite capitalLightswitch capitalNarya capitalTranshuman capital

Sanofi Strikes Deal With Mysterious Psychedelics Biotech Terran

New York-based Terran Biosciences inked a deal with Paris-based Sanofi for two late-stage central nervous system (CNS) assets. Terran plans to advance them for neurological and psychological indications.

Comunidad autonoma de catalunaRiba serranoRiba blumentechSam clarkMarc ribaJordi riba serranoUniversity of marylandNoetic fundSant pau biomedical research instituteImpact foundationResearch foundation for mental hygieneColumbia universityYork based terran biosciencesParis based sanofiInvestigational new drugGerard de lucas

After $100M round, RTP startup Kryia Therapeutics spins out new group focusing on eye diseases

Editor's note: This story is another in the "Startup Spotlight" series which brings into greater view emerging and new technologies. This post is from the N.C.

North carolinaUnited statesPalo altoResearch triangle parkTheresa heahFraser wrightRoger jeffsShankar ramaswamyDexcel pharmaGenetic technologies corporationFovea pharmaceuticalsRd fundResearch triangleAerie pharmaceuticalsNc biotech centerKriya therapeutics